HLC8 Antikörper (FITC)
Kurzübersicht für HLC8 Antikörper (FITC) (ABIN2175885)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human HLC8/Lung cancer related protein 8
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- HLC8 (C17orf80) (Chromosome 17 Open Reading Frame 80 (C17orf80))
-
Andere Bezeichnung
- HLC8
-
Hintergrund
-
Synonyms: Cell migration inducing gene 3 protein, Chromosome 17 open reading frame 80, FLJ20721, HLC 8, HLC-8, C17orf80, Human lung cancer oncogene 8 protein, Lung cancer related protein 8, MIG3, Migration inducing protein 3, Uncharacterized protein C17orf80, CQ080_HUMAN.
Background: HLC8
-
Gen-ID
- 55028
Target
-